共 158 条
[1]
Manack AN(2015)Disease and injury incidence and prevalence collaborators (2016) global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the global burden of disease study 2015 Lancet 388 1545-1602
[2]
Buse DC(2011)Chronic migraine: epidemiology and disease burden Curr Pain Headache Rep 15 70-78
[3]
Lipton RB(2010)Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers J Neurol Neurosurg Psychiatry 81 428-432
[4]
Buse DC(2018)The journey from genetic predisposition to medication overuse headache to its acquisition as sequela of chronic migraine J Headache Pain 19 2-483
[5]
Manack A(2004)Medication-overuse headache: a worldwide problem Lancet Neurol 8 475-909
[6]
Serrano D(2015)Drug safety in acute migraine treatment Expert Opin Drug Saf 14 891-803
[7]
Turkel C(2015)Validation of potential candidate biomarkers of drug-induced nephrotoxicity and allodynia in medication-overuse headache J Headache Pain 16 559-814
[8]
Lipton RB(2010)OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial Cephalalgia 30 793-936
[9]
Martelletti P(2010)OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial Cephalalgia 30 804-1373
[10]
Diener HC(2010)OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program Headache 50 921-1789